Individuals, patients, patient organisations, health professionals, researchers, drug developers, public health authorities - join this year's campaign!
Home / Newsroom / Press releases / NAFLD and NASH linked to metabolic syndrome and cardiovascular disease
NAFLD and NASH linked to metabolic syndrome and cardiovascular disease
Patients with fatty liver are at increased risk of cardiovascular disease. Prevalence estimates vary widely and approach 25% among adults. Risk factors for fatty liver include overweight type 2 diabetes and sedentary lifestyle.
